Stifel Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $274M | Buy |
9,769,180
+491,819
| +5% | +$13.1M | 0.25% | 91 |
|
|
2025
Q4 | $231M | Sell |
9,277,361
-76,536
| -0.8% | -$1.93M | 0.21% | 114 |
|
|
2025
Q3 | $238M | Sell |
9,353,897
-53,539
| -0.6% | -$1.32M | 0.22% | 104 |
|
|
2025
Q2 | $228M | Sell |
9,407,436
-77,152
| -0.8% | -$1.8M | 0.22% | 103 |
|
|
2025
Q1 | $240M | Buy |
9,484,588
+396,784
| +4% | +$10.4M | 0.26% | 85 |
|
|
2024
Q4 | $241M | Sell |
9,087,804
-287,478
| -3% | -$7.8M | 0.25% | 91 |
|
|
2024
Q3 | $271M | Buy |
9,375,282
+688,264
| +8% | +$20.1M | 0.28% | 82 |
|
|
2024
Q2 | $243M | Buy |
8,687,018
+346,682
| +4% | +$9.54M | 0.27% | 84 |
|
|
2024
Q1 | $231M | Buy |
8,340,336
+1,304,083
| +19% | +$36.2M | 0.26% | 88 |
|
|
2023
Q4 | $203M | Sell |
7,036,253
-6,699,381
| -49% | -$203M | 0.25% | 90 |
|
|
2023
Q3 | $456M | Buy |
13,735,634
+465,039
| +4% | +$16.4M | 0.64% | 25 |
|
|
2023
Q2 | $487M | Buy |
13,270,595
+356,136
| +3% | +$13.9M | 0.67% | 24 |
|
|
2023
Q1 | $527M | Buy |
12,914,459
+718,353
| +6% | +$31M | 0.76% | 20 |
|
|
2022
Q4 | $625M | Buy |
12,196,106
+338,541
| +3% | +$16.2M | 0.94% | 11 |
|
|
2022
Q3 | $519M | Sell |
11,857,565
-962,856
| -8% | -$46.8M | 0.85% | 13 |
|
|
2022
Q2 | $672M | Buy |
12,820,421
+509,852
| +4% | +$26M | 1.05% | 9 |
|
|
2022
Q1 | $637M | Buy |
12,310,569
+501,296
| +4% | +$26M | 0.87% | 12 |
|
|
2021
Q4 | $697M | Buy |
11,809,273
+77,378
| +0.7% | +$3.83M | 0.92% | 12 |
|
|
2021
Q3 | $505M | Buy |
11,731,895
+431,206
| +4% | +$19.1M | 0.74% | 21 |
|
|
2021
Q2 | $443M | Buy |
11,300,689
+476,248
| +4% | +$18.5M | 0.66% | 25 |
|
|
2021
Q1 | $392M | Buy |
10,824,441
+26,052
| +0.2% | +$925K | 0.65% | 30 |
|
|
2020
Q4 | $397M | Sell |
10,798,389
-9,886
| -0.1% | -$363K | 0.71% | 24 |
|
|
2020
Q3 | $376M | Buy |
10,808,275
+604,141
| +6% | +$21.2M | 0.77% | 21 |
|
|
2020
Q2 | $317M | Buy |
10,204,134
+440,656
| +5% | +$15M | 0.73% | 21 |
|
|
2020
Q1 | $302M | Buy |
9,763,478
+218,590
| +2% | +$7.45M | 0.83% | 16 |
|
|
2019
Q4 | $355M | Buy |
9,544,888
+1,944,668
| +26% | +$69.3M | 0.74% | 17 |
|
|
2019
Q3 | $259M | Buy |
7,600,220
+542,866
| +8% | +$19.7M | 0.66% | 26 |
|
|
2019
Q2 | $290M | Buy |
7,057,354
+516,985
| +8% | +$20.5M | 0.75% | 17 |
|
|
2019
Q1 | $263M | Buy |
6,540,369
+10,098
| +0.2% | +$404K | 0.74% | 17 |
|
|
2018
Q4 | $270M | Sell |
6,530,271
-75,152
| -1% | -$3.12M | 0.87% | 13 |
|
|
2018
Q3 | $276M | Buy |
6,605,423
+145,840
| +2% | +$5.61M | 0.79% | 16 |
|
|
2018
Q2 | $223M | Sell |
6,459,583
-669,484
| -9% | -$22.9M | 0.68% | 21 |
|
|
2018
Q1 | $240M | Sell |
7,129,067
-166,275
| -2% | -$5.72M | 0.76% | 15 |
|
|
2017
Q4 | $251M | Sell |
7,295,342
-462,300
| -6% | -$15.8M | 0.79% | 11 |
|
|
2017
Q3 | $263M | Sell |
7,757,642
-101,494
| -1% | -$3.26M | 0.91% | 10 |
|
|
2017
Q2 | $250M | Buy |
7,859,136
+132,925
| +2% | +$4.19M | 0.93% | 9 |
|
|
2017
Q1 | $251M | Buy |
7,726,211
+798,830
| +12% | +$25.2M | 0.97% | 9 |
|
|
2016
Q4 | $213M | Sell |
6,927,381
-69,268
| -1% | -$2.11M | 0.91% | 11 |
|
|
2016
Q3 | $225M | Buy |
6,996,649
+10,063
| +0.1% | +$336K | 1.01% | 9 |
|
|
2016
Q2 | $233M | Buy |
6,986,586
+877,353
| +14% | +$28M | 1.08% | 9 |
|
|
2016
Q1 | $172M | Buy |
6,109,233
+231,229
| +4% | +$6.6M | 0.92% | 11 |
|
|
2015
Q4 | $180M | Buy |
5,878,004
+271,661
| +5% | +$8.55M | 0.94% | 10 |
|
|
2015
Q3 | $167M | Buy |
5,606,343
+170,737
| +3% | +$5.47M | 0.94% | 11 |
|
|
2015
Q2 | $173M | Buy |
5,435,606
+577,376
| +12% | +$18.8M | 0.89% | 9 |
|
|
2015
Q1 | $160M | Buy |
4,858,230
+284,335
| +6% | +$9.04M | 0.88% | 6 |
|
|
2014
Q4 | $135M | Buy |
4,573,895
+1,242,909
| +37% | +$35.6M | 0.75% | 13 |
|
|
2014
Q3 | $93.4M | Buy |
3,330,986
+68,219
| +2% | +$1.91M | 0.82% | 9 |
|
|
2014
Q2 | $91.9M | Buy |
3,262,767
+555,855
| +21% | +$15.8M | 0.83% | 10 |
|
|
2014
Q1 | $82.5M | Buy |
+2,706,912
| New | +$80.7M | 0.79% | 10 |
|
Other funds holding PFE
VCM
VPM
Stifel Financial's PFE Position: Q1 2026 in Review
Stifel Financial increased its Pfizer (PFE) stake by 5.3% in Q1 2026, buying an estimated $13.1M and bringing the position to 9,769,180 shares worth $274M. The position accounts for 0.25% of the portfolio, ranked #91.
Stifel Financial first reported a position in PFE in Q1 2014 and has held it in 49 quarters since. The position peaked at $697M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Stifel Financial held 9,769,180 shares of Pfizer worth $274M as of Q1 2026.
- Stifel Financial bought 491,819 Pfizer shares in Q1 2026, an estimated $13.1M.
- Pfizer made up 0.25% of Stifel Financial's portfolio in Q1 2026, its #91 holding.
- Stifel Financial first reported a position in Pfizer in Q1 2014 and has held it in 49 quarters since.
- Stifel Financial's Pfizer position peaked at $697M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Stifel Financial's 13F filing for Q1 2026, filed 12 May 2026.